Physician profile
Jeffrey J Thomas
NPI 1215935531
$717.60
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $73.64 · 2021: $39.10 · 2023: $46.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $132.76 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $102.29 | 2019-2023 | |
| Novo Nordisk INC | $76.54 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.53 | 2019-2020 | |
| Pfizer INC. | $75.46 | 2019-2020 | |
| Amgen INC. | $51.98 | 2019 | |
| Abbvie INC. | $39.10 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $32.08 | 2019 | |
| Orthofix Medical, INC. | $30.05 | 2023 | Spinal-Stim, Physio-Stim |
| Glaxosmithkline, LLC. | $26.47 | 2019 | |
| Merck Sharp & Dohme LLC | $25.26 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.